Literature DB >> 20465577

Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells.

Subramanya Hegde1, Lisa Fox, Xiaohua Wang, Jenny E Gumperz.   

Abstract

Natural killer T (NKT) cells are innate T lymphocytes that are restricted by CD1d antigen-presenting molecules and recognize lipids and glycolipids as antigens. NKT cells have attracted attention for their potent immunoregulatory effects. Like other types of regulatory lymphocytes, a high proportion of NKT cells appear to be autoreactive to self antigens. Thus, as myeloid antigen-presenting cells (APCs) such as monocytes, dendritic cells (DCs) and myeloid-derived suppressor cells (MDSCs) constitutively express CD1d, NKT cells are able to interact with these APCs not only during times of immune activation but also in immunologically quiescent periods. The interactions of NKT cells with myeloid APCs can have either pro-inflammatory or tolerizing outcomes, and a central question is how the ensuing response is determined. Here we bring together published results from a variety of model systems to highlight three critical factors that influence the outcome of the NKT-APC interaction: (i) the strength of the antigenic signal delivered to the NKT cell, as determined by antigen abundance and/or T-cell receptor (TCR) affinity; (ii) the presence or absence of cytokines that costimulate NKT cells [e.g. interleukin (IL)-12, IL-18 and interferon (IFN)-alpha]; (iii) APC intrinsic factors such as differentiation state (e.g. monocyte versus DC) and Toll-like receptor (TLR) stimulation. Together with recent findings that demonstrate new links between NKT cell activation and endogenous lipid metabolism, these results outline a picture in which the functions of NKT cells are closely attuned to the existing biological context. Thus, NKT cells may actively promote tolerance until a critical level of danger signals arises, at which point they switch to activating pro-inflammatory immune responses.

Entities:  

Mesh:

Year:  2010        PMID: 20465577      PMCID: PMC2913258          DOI: 10.1111/j.1365-2567.2010.03293.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  133 in total

1.  Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity.

Authors:  Keunhee Oh; Sanghee Kim; Se-Ho Park; Hua Gu; Derry Roopenian; Doo Hyun Chung; Yon Su Kim; Dong-Sup Lee
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

2.  CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool.

Authors:  J P Rosat; E P Grant; E M Beckman; C C Dascher; P A Sieling; D Frederique; R L Modlin; S A Porcelli; S T Furlong; M B Brenner
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

3.  Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; H Sato; E Kondo; M Harada; H Koseki; T Nakayama; Y Tanaka; M Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 4.  Phospholipase A2.

Authors:  Makoto Murakami; Ichiro Kudo
Journal:  J Biochem       Date:  2002-03       Impact factor: 3.387

5.  Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.

Authors:  Mark J Smyth; Nadine Y Crowe; Daniel G Pellicci; Konstantinos Kyparissoudis; Janice M Kelly; Kazuyoshi Takeda; Hideo Yagita; Dale I Godfrey
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

6.  Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells.

Authors:  Nadia Duarte; Martin Stenström; Susana Campino; Marie-Louise Bergman; Marie Lundholm; Dan Holmberg; Susanna L Cardell
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

7.  Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.

Authors:  Karsten Fischer; Emmanuel Scotet; Marcus Niemeyer; Heidrun Koebernick; Jens Zerrahn; Sophie Maillet; Robert Hurwitz; Mischo Kursar; Marc Bonneville; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-08       Impact factor: 11.205

8.  An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity.

Authors:  Yeonseok Chung; Hong Qin; Chang-Yuil Kang; Sanghee Kim; Larry W Kwak; Chen Dong
Journal:  Blood       Date:  2007-06-20       Impact factor: 22.113

9.  Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.

Authors:  Julia M Tulley; Jessica L Palmer; Richard L Gamelli; Douglas E Faunce
Journal:  Shock       Date:  2008-02       Impact factor: 3.454

10.  Human NKT cells promote monocyte differentiation into suppressive myeloid antigen-presenting cells.

Authors:  Subramanya Hegde; Ewa Jankowska-Gan; Drew A Roenneburg; Jose Torrealba; William J Burlingham; Jenny E Gumperz
Journal:  J Leukoc Biol       Date:  2009-10       Impact factor: 4.962

View more
  33 in total

1.  Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type.

Authors:  Y-G Chen; S-W Tsaih; D V Serreze
Journal:  Genes Immun       Date:  2011-09-22       Impact factor: 2.676

2.  A novel axis of innate immunity in cancer.

Authors:  Stephen R Mattarollo; Mark J Smyth
Journal:  Nat Immunol       Date:  2010-11       Impact factor: 25.606

3.  CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis.

Authors:  D Petrovic-Djergovic; M Popovic; S Chittiprol; H Cortado; R F Ransom; S Partida-Sánchez
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

Review 4.  The liver works as a school to educate regulatory immune cells.

Authors:  Fenglei Li; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

Review 5.  In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes.

Authors:  Valentina Di Caro; Nick Giannoukakis; Massimo Trucco
Journal:  Rev Diabet Stud       Date:  2012-12-28

6.  Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands.

Authors:  Subramanya Hegde; Jennifer L Lockridge; Yusof A Becker; Shidong Ma; Shannon C Kenney; Jenny E Gumperz
Journal:  J Autoimmun       Date:  2011-04-12       Impact factor: 7.094

Review 7.  What rheumatologists need to know about innate lymphocytes.

Authors:  Mark A Exley; George C Tsokos; Kingston H G Mills; Dirk Elewaut; Ben Mulhearn
Journal:  Nat Rev Rheumatol       Date:  2016-09-02       Impact factor: 20.543

8.  Activation of glioma cells generates immune tolerant NKT cells.

Authors:  Bo Tang; Wei Wu; Xiaowei Wei; Yang Li; Gang Ren; Wenhai Fan
Journal:  J Biol Chem       Date:  2014-10-23       Impact factor: 5.157

Review 9.  Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.

Authors:  Mark A Exley; Lydia Lynch; Bindu Varghese; Michael Nowak; Nadia Alatrakchi; Steven P Balk
Journal:  Clin Immunol       Date:  2011-05-13       Impact factor: 3.969

Review 10.  Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement.

Authors:  Elad Neeman; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2012-04-04       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.